Search research articles
Contact Us
Filters
Showing results (11-20 of 206) with videos related to
Page
of 21
Sort By:
The New England Journal of Medicine
|
June 20, 1974
Editorial: Hypoalimentation during hyperalimentation
M A Lichtman
Leukemia
|
July 12, 2013
Understanding the mutational evolution of clonal cytopenias and oligoblastic myelogenous leukemia ('myelodysplasia')
M A Lichtman
Blood Cells, Molecules & Diseases
|
November 17, 2012
A historical perspective on the development of the cytarabine (7days) and daunorubicin (3days) treatment regimen for acute myelogenous leukemia: 2013 the 40th anniversary of 7+3
Marshall A Lichtman
Leukemia
|
May 23, 2001
Introduction of Ernest Beutler, MD
M A Lichtman
Leukemia
|
July 23, 2011
Obesity and the risk of chronic myelogenous leukemia: is this another example of the neoplastic effects of increased body fat?
M A Lichtman
The American Journal of Medical Technology
|
February 1, 1983
Hemopoietic stem cell disorders
M A Lichtman
Blood Cells, Molecules & Diseases
|
August 3, 2001
Differentiation versus maturation of neoplastic hematopoietic cells: an important distinction
M A Lichtman
Blood Cells, Molecules & Diseases
|
February 12, 2021
Oligomonocytic chronic myelomonocytic leukemia. Thoughts and suggestions
Marshall A Lichtman
The New England Journal of Medicine
|
October 29, 1970
Cellular deformability during maturation of the myeloblast. Possible role in marrow egress
M A Lichtman
The Oncologist
|
February 29, 2008
Battling the hematological malignancies: the 200 years' war
Marshall A Lichtman
Page
of 21
Search research articles
Search
Showing results (11-20 of 206) with videos related to
Sort By:
Page
of 21
The New England Journal of Medicine
|
June 20, 1974
Editorial: Hypoalimentation during hyperalimentation
M A Lichtman
Leukemia
|
July 12, 2013
Understanding the mutational evolution of clonal cytopenias and oligoblastic myelogenous leukemia ('myelodysplasia')
M A Lichtman
Blood Cells, Molecules & Diseases
|
November 17, 2012
A historical perspective on the development of the cytarabine (7days) and daunorubicin (3days) treatment regimen for acute myelogenous leukemia: 2013 the 40th anniversary of 7+3
Marshall A Lichtman
Leukemia
|
May 23, 2001
Introduction of Ernest Beutler, MD
M A Lichtman
Leukemia
|
July 23, 2011
Obesity and the risk of chronic myelogenous leukemia: is this another example of the neoplastic effects of increased body fat?
M A Lichtman
The American Journal of Medical Technology
|
February 1, 1983
Hemopoietic stem cell disorders
M A Lichtman
Blood Cells, Molecules & Diseases
|
August 3, 2001
Differentiation versus maturation of neoplastic hematopoietic cells: an important distinction
M A Lichtman
Blood Cells, Molecules & Diseases
|
February 12, 2021
Oligomonocytic chronic myelomonocytic leukemia. Thoughts and suggestions
Marshall A Lichtman
The New England Journal of Medicine
|
October 29, 1970
Cellular deformability during maturation of the myeloblast. Possible role in marrow egress
M A Lichtman
The Oncologist
|
February 29, 2008
Battling the hematological malignancies: the 200 years' war
Marshall A Lichtman
Page
of 21